Physician profile
Robert Henry Routh
NPI 1992932776
$1,345.95
in general payments reported to CMS, 2019-2025
18 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $42.53 · 2021: $150 · 2022: $399 · 2023: $198 · 2024: $283 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.50 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $360.08 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Ocular Therapeutix, INC. | $250.74 | 2023-2025 | Dextenza |
| Alcon Vision LLC | $195.05 | 2019-2025 | Centurion, Hydrus Microstent |
| Glaukos Corporation | $102.20 | 2024-2025 | Idose, Idosetr, Radius |
| Sun Pharmaceutical Industries INC. | $87.09 | 2019-2021 | |
| Heru, INC. | $68.20 | 2022 | |
| Allergan, INC. | $50.15 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.32 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $32.78 | 2022-2023 | Tecnis Simplicity |
| Sight Sciences, INC. | $30.38 | 2021-2022 | |
| Dompe US, INC. | $24.22 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.60 | 2021 | |
| Omeros Corporation | $18.52 | 2019 | |
| Kala Pharmaceuticals, INC. | $18.49 | 2021 | |
| Eyepoint US, INC. | $18.31 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.30 | 2022 | |
| Oyster Point Pharma, INC. | $14.52 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Routh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.